| Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ... The Lancet 389 (10064), 37-55, 2017 | 2978 | 2017 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The lancet 398 (10304), 957-980, 2021 | 2859 | 2021 |
| FinnGen provides genetic insights from a well-phenotyped isolated population MI Kurki, J Karjalainen, P Palta, TP Sipilä, K Kristiansson, KM Donner, ... Nature 613 (7944), 508-518, 2023 | 2030 | 2023 |
| 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by … G Mancia, R Kreutz, M Brunström, M Burnier, G Grassi, A Januszewicz, ... Journal of hypertension 41 (12), 1874-2071, 2023 | 1860 | 2023 |
| Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits E Evangelou, HR Warren, D Mosen-Ansorena, B Mifsud, R Pazoki, H Gao, ... Nature genetics 50 (10), 1412-1425, 2018 | 1367 | 2018 |
| Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure S Shah, A Henry, C Roselli, H Lin, G Sveinbjörnsson, G Fatemifar, ... Nature communications 11 (1), 163, 2020 | 699 | 2020 |
| Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk HR Warren, E Evangelou, CP Cabrera, H Gao, M Ren, B Mifsud, I Ntalla, ... Nature genetics 49 (3), 403-415, 2017 | 623 | 2017 |
| Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys B Zhou, G Danaei, GA Stevens, H Bixby, C Taddei, RM Carrillo-Larco, ... The Lancet 394 (10199), 639-651, 2019 | 532 | 2019 |
| Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study TJ Niiranen, MR Hänninen, J Johansson, A Reunanen, AM Jula Hypertension 55 (6), 1346-1351, 2010 | 529 | 2010 |
| Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for … C Magnussen, TJ Niiranen, FM Ojeda, F Gianfagna, S Blankenberg, ... Circulation 136 (17), 1588-1597, 2017 | 521 | 2017 |
| Sex differences in blood pressure trajectories over the life course H Ji, A Kim, JE Ebinger, TJ Niiranen, BL Claggett, CNB Merz, S Cheng JAMA cardiology 5 (3), 255-262, 2020 | 458 | 2020 |
| FinnGen: Unique genetic insights from combining isolated population and national health register data MI Kurki, J Karjalainen, P Palta, TP Sipilä, K Kristiansson, K Donner, ... medrxiv, 2022.03. 03.22271360, 2022 | 443 | 2022 |
| Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome GS Stergiou, K Asayama, L Thijs, A Kollias, TJ Niiranen, A Hozawa, ... Hypertension 63 (4), 675-682, 2014 | 383* | 2014 |
| Stroke genetics informs drug discovery and risk prediction across ancestries A Mishra, R Malik, T Hachiya, T Jürgenson, S Namba, DC Posner, ... Nature 611 (7934), 115-123, 2022 | 340 | 2022 |
| Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort Y Qin, AS Havulinna, Y Liu, P Jousilahti, SC Ritchie, A Tokolyi, ... Nature Genetics 54 (2), 134-142, 2022 | 322 | 2022 |
| Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study JK Johansson, TJ Niiranen, PJ Puukka, AM Jula Hypertension 59 (2), 212-218, 2012 | 307 | 2012 |
| Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium FJ Brunner, C Waldeyer, F Ojeda, V Salomaa, F Kee, S Sans, B Thorand, ... The Lancet 394 (10215), 2173-2183, 2019 | 296 | 2019 |
| Repositioning of the global epicentre of non-optimal cholesterol Nature 582 (7810), 73-77, 2020 | 239 | 2020 |
| Lipoprotein (a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium C Waldeyer, N Makarova, T Zeller, RB Schnabel, FJ Brunner, ... European heart journal 38 (32), 2490-2498, 2017 | 235 | 2017 |
| Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions–position statement of the … GS Stergiou, G Parati, C Vlachopoulos, A Achimastos, E Andreadis, ... Journal of hypertension 34 (9), 1665-1677, 2016 | 205 | 2016 |
Susan ChengCedars-Sinai Medical CenterEmail verificata su cshs.org
